Amarex today announced its work on behalf of Britecyte has resulted in a "safe to proceed" status by the United States Food and Drug Administration (FDA) for its Adipose Tissue Allograft (BRC-OA). BRC ...

The US Food and Drug Administration (FDA) has granted Regenerative Medicine Advanced Therapy (RMAT) designation to AskBio’s investigational Parkinson’s disease (PD) gene therapy. The FDA grants RMAT ...

AskBio’s gene therapy AB-1005 to treat Parkinson’s disease receives US FDA Regenerative Medicine Advanced Therapy designation: Berlin, Germany Thursday, February 20, 2025, 10: ...

Berlin, Germany, and Research Triangle Park, N.C., USA, Feb. 19, 2025 (GLOBE NEWSWIRE) -- Not intended for UK MediaRegenerative Medicine ...

Researchers from Tokyo Metropolitan University have developed a way to treat ageing-related muscular atrophy using ...

Researchers have developed a regenerative medicine method that successfully grafts myoblasts onto healthy muscle, boosting ...

Researchers from Tokyo Metropolitan University have developed a way to treat age-related muscular atrophy using regenerative ...